Pricing Log in Create free account

BeyondSpring Inc. (BYSI) vs Prima BioMed Ltd (IMMP)

BeyondSpring Inc. and Prima BioMed Ltd are both Biotechnology companies. BeyondSpring Inc. and Prima BioMed Ltd are of similar size ($23.9M and $23.7M). Across the 8 metrics below, BeyondSpring Inc. leads on 4 and Prima BioMed Ltd on 4.

Valuation

Metric BYSI IMMP Biotechnology median
P/E n/m n/m 8.50
P/S 17.04 n/m 9.71
P/B n/m 0.05 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 13.84 n/m 9.21
Earnings yield (46.95%) (40.42%) (33.15%)
Free cash flow yield (72.94%) (1,275.20%) (25.50%)

Profitability

Metric BYSI IMMP Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 24.96% 0.00% (56.36%)
Return on assets (29.29%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BYSI IMMP Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 96.30% (33.84%) 30.26%
Revenue growth, 5-year CAGR — 40.79% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BYSI IMMP Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 0.70 2.97 4.72
Net debt to EBITDA 1.42 0.92 0.96

Dividend

Metric BYSI IMMP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BYSI IMMP Biotechnology median
Market cap 23.93m 23.66m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack